Clinical Research

Abstract 2703: Loss of dependence on EGFR signaling by upregulation of Mig6 confers drug resistance to erlotinib.

Clinical Research

Xiaofei Chang, Aditi Chatterjee, Shyhmin Huang, Myoung Sook Kim, Chunbo Shao, Constance L. Monitto, Patrick K. Ha, Manuel Hidalgo, Paul M. Harari, David M. Berman, Atul Bedi, David Sidransky

Oral, Head & Neck Cancer Research Group

Abstract 2703: Loss of dependence on EGFR signaling by upregulation of Mig6 confers drug resistance to erlotinib.

Seminar Schedule

UCSF News

Prostate Cancer Study: More Health Benefits from Plant-Based Diet

Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?

UCSF Scientists Build a Molecular ‘GPS’ to Guide Cell Therapies

Can a New Drug Candidate Cure Pancreatic Cancer?

Oral, Head & Neck Cancer Research Group

Search form

You are here

Clinical Research

Abstract 2703: Loss of dependence on EGFR signaling by upregulation of Mig6 confers drug resistance to erlotinib.

Seminar Schedule

UCSF News

Prostate Cancer Study: More Health Benefits from Plant-Based Diet

Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?

UCSF Scientists Build a Molecular ‘GPS’ to Guide Cell Therapies

Can a New Drug Candidate Cure Pancreatic Cancer?